Assessment of Gesture Accuracy of a Prosthesis Control System

Last updated: October 8, 2024
Sponsor: Phantom Neuro Inc.
Overall Status: Active - Recruiting

Phase

1

Condition

N/A

Treatment

Non-invasive EMG band instrumentation

Clinical Study ID

NCT06446037
PN01
  • Ages > 21
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The study is evaluating the performance of prosthesis control system, referred to as Phantom X, in able bodied individuals and individuals with upper limb amputation at the forearm level.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Individuals 21 years in age and older

  2. Individuals with amputation of one or both arms at transradial level (applies toamputees only)

  3. Ability to follow study directions

  4. Willingness and ability to sign Informed Consent

Exclusion

Exclusion Criteria:

  1. Individuals with previously diagnosed muscle pathologies

  2. Individuals with impaired muscle function and/or impaired ability to perform normalhand movements (normal participants) or ability to perform normal phantom handmovements (amputees)

  3. Individuals with transhumeral or higher amputation of both arms (applies to amputeesonly)

  4. Cognitively impaired to follow study instructions

  5. Allergies to skin adhesive materials necessary for cutaneous electrode placement

  6. Excessive hair growth on arms and inability to shave off the hair for electrodeplacement

  7. Pregnant woman

  8. Arms or residual limbs with insufficient diameter to accommodate the wearing of twocutaneous sensor arrays

  9. Injuries, bruises, or open wounds on the arm that needs to be instrumented for thestudy

Study Design

Total Participants: 25
Treatment Group(s): 1
Primary Treatment: Non-invasive EMG band instrumentation
Phase: 1
Study Start date:
August 13, 2024
Estimated Completion Date:
December 31, 2024

Study Description

The study will characterize the performance of Phantom X system and associated algorithms in decoding EMG signals for various hand gesture control. The EMG signals will be sensed using a non-invasive multi-electrode array applied to subjects' forearms.

Connect with a study center

  • Phantom Neuro Inc. Operational Headquarters

    Austin, Texas 78704
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.